Ravi, R., Noonan, K. A., Pham, V., Bedi, R., Zhavoronkov, A., Ozerov, I. V., . . . Bedi, A. (2018). Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFβ enhance the efficacy of cancer immunotherapy. Nat Commun.
Chicago Style CitationRavi, Rajani, et al. "Bifunctional Immune Checkpoint-targeted Antibody-ligand Traps That Simultaneously Disable TGFβ Enhance the Efficacy of Cancer Immunotherapy." Nat Commun 2018.
MLA CitationRavi, Rajani, et al. "Bifunctional Immune Checkpoint-targeted Antibody-ligand Traps That Simultaneously Disable TGFβ Enhance the Efficacy of Cancer Immunotherapy." Nat Commun 2018.
Warning: These citations may not always be 100% accurate.